Medical egg freezing: How cost and lack of insurance cover impact women and their families

Marcia C. Inhorn, Daphna Birenbaum-Carmeli, Lynn M. Westphal, Joseph Doyle, Norbert Gleicher, Dror Meirow, Hila Raanani, Martha Dirnfeld, Pasquale Patrizio

Research output: Contribution to journalArticlepeer-review

Abstract

Medical egg freezing (MEF) is being recommended increasingly for women at risk of losing their reproductive ability due to cancer chemotherapy or other fertility-threatening medical conditions. This first, binational, ethnographic study of women who had undergone MEF sought to explore women's experiences under two different funding systems: (i) the USA, where the cost of MEF is rarely covered by private or state health insurance; and (ii) Israel, where the cost of MEF is covered by national health insurance. Women were recruited from four American and two Israeli in-vitro fertilization clinics where MEF is offered. In-depth, semi-structured interviews were conducted with 45 women (33 Americans, 12 Israelis) who had completed at least one cycle of MEF. All of the Israeli women had cancer diagnoses, but were not faced with the additional burden of funding an MEF cycle. In marked contrast, the American women – 23 with cancer diagnoses and 10 with other fertility-threatening medical conditions – struggled, along with their families, to ‘piece together’ MEF funding, which added significant financial pressure to an already stressful situation. Given the high priority that both American and Israeli women in this study placed on survival and future motherhood, it is suggested that insurance funding for MEF should be mandated in the USA, as it is in Israel. This article concludes by describing new state legislative efforts in this regard.

Original languageEnglish
Pages (from-to)82-92
Number of pages11
JournalReproductive Biomedicine and Society Online
Volume5
DOIs
StatePublished - Apr 2018

Bibliographical note

Funding Information:
The authors wish to thank Jennifer DeChello, Jeannine Estrada, Rose Keimig, Sandee Murray, Tasha Newsome, Mira Vale and Ruoxi Yu for various forms of editorial, study recruitment and transcription assistance. This study was generously funded by a grant from the US National Science Foundation [BCS-1356136, Principal Investigator (PI) Marcia C. Inhorn, Co-PI Pasquale Patrizio).

Funding Information:
The authors wish to thank Jennifer DeChello, Jeannine Estrada, Rose Keimig, Sandee Murray, Tasha Newsome, Mira Vale and Ruoxi Yu for various forms of editorial, study recruitment and transcription assistance. This study was generously funded by a grant from the US National Science Foundation [ BCS-1356136 , Principal Investigator (PI) Marcia C. Inhorn, Co-PI Pasquale Patrizio).

Publisher Copyright:
© 2018 The Authors

Keywords

  • Israel
  • USA
  • cancer
  • fertility preservation
  • insurance coverage
  • medical egg freezing

ASJC Scopus subject areas

  • Health(social science)
  • Cultural Studies
  • Reproductive Medicine
  • Developmental Biology

Fingerprint

Dive into the research topics of 'Medical egg freezing: How cost and lack of insurance cover impact women and their families'. Together they form a unique fingerprint.

Cite this